Location	Usual name	protein name	Sequence change	Alteration	N base(s)	Base substituted	Classification	Status	Using In silico prediction?	Fonctional test	Functional approach?	Consequence	N controls	Techniques used	Change/define RFLP	Disease related symptoms	Associated phenotype	Ancestry/origin	Comment	Input date	References
5 flanking 	-609 G/T		c.-610G>T	substitution	1	G>T	Not classified		UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	/	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication (usual name)	2003-04-23	Weinshenker  BG et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10227645
5 flanking 	-580 A/G		c.-581A>G	substitution	1	A>G	Not classified		UNKNOWN	NO			124	Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	African American/African American	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication (usual name)	2003-08-04	Bridges SL Jr  Jenq G  Moran M  Kuffner T  Whitworth WC  McNicholl J   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/12209507
5 flanking 	c.-559G>A		c.-559G>A	substitution	1	G>A	Not classified		UNKNOWN	NO			17	Sequencing Sanger 	UNKNOWN	Non symptomatic 	NO	France/Caucasian		2011-06-10	Rittore C  Grandemange S  Touitou I   Personal communication
5 flanking 	-508 A/G		c.-508A>G	substitution	1	A>G	Not classified		UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	/	  	2003-07-14	Weinshenker BG  Hebrink D  Wingerchuk DM  Klein CJ  Atkinson E  O'Brien PC  McMurray CT.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10227645
5 flanking 	-383 A/C		c.-383A>C	substitution	1	A>C	Not classified		UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	United kingdom/	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication (usual name) to comply with the current nomenclature  	2003-04-25	Pitts SA  et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/9615918
Exon 1	c.15C>T	p.(=)	c.15C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	Italia/		2017-08-21	Isabella Ceccherini   Personal communication
Exon 1	c.36 A>G	p.(=)	c.36A>G	substitution	1	A>G	Benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	United kingdom/	Non-coding change in residue 12 - Proline 	2003-04-25	 Pitts SA et al.   Bazzoni F  et al    Publication (Medline Abstract): "http://www.ncbi.nlm.nih.gov/pubmed/9615917 ;  http://www.ncbi.nlm.nih.gov/pubmed/10663579"
Intron 1	c.39+97G>A		c.39+97G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO			17	Sequencing Sanger 	UNKNOWN	Non symptomatic 	NO	France/Caucasian		2011-06-10	c.39+97G>A   Personal communication
Intron 1	c.39+1899(GT)n(GA)n		c.39+1899(GT)17(GA)10	duplication	10	GTGA	Not classified		UNKNOWN	NO			143	Sequencing Sanger Southern-Blot 	NO	Non symptomatic 	NO	United kingdom/	    	2003-07-14	Eskdale J  Turestkaya RL  Armstrong C  Kuprash DV  Nedospasov SA  Gallagher G.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11196717
Intron 1	c.40-3367C>T		c.40-3367C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	UNKNOWN			2949	Sequencing Sanger 	UNKNOWN	Symptomatic Non symptomatic 	MS	Spain/Caucasian	Mild association with MS in spain	2012-06-01	Swaminathan B et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/20430450
Intron 1	c.40-981C>T		c.40-981C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			17	Sequencing Sanger 	UNKNOWN	Non symptomatic 	NO	France/Caucasian		2011-06-10	Rittore C  Grandemange S  Touitou I   Personal communication
Exon 2	c.59T>C	p.Val20Ala	c.59T>C	substitution	1	T>C	Uncertain significance (VOUS)	PROVISIONAL	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United states/Caucasian		2011-08-24	Yao  QP Yerian  L Shen  B   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed?term=yao%20and%20v20a
Exon 2	c.81T>C	p.(=)	c.81T>C	substitution	1	T>C	Likely benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	Italy/Caucasian		2017-08-18	Isabella Ceccherini   Personal communication
Exon 2	D12E	p.Asp41Glu	c.123T>G	substitution	1	T>G	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	NO			400	Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	Italy/		2006-03-09	D'Osualdo et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16508982
Exon 2	C15Y	p.Cys44Tyr	c.131G>A	substitution	1	G>A	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN		amino acid exchange  		Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	Austria/		2017-01-23	Witsch-Baumgartner M  Maurer E.   Personal communication
Exon 2	Y20H	p.Tyr49His	c.145T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	France/Jewish Non Ashkenasi	  	2002-10-25	Dodé  C et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/12209523
Exon 2	Y20D	p.Tyr49Asp	c.145T>G	substitution	1	T>G	Pathogenic	VALIDATED	UNKNOWN	NO			200	Sequencing Sanger 	creates EcoRV gat/atc	Symptomatic 	UNKNOWN	China/	 	2003-11-21	Stojanov S et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15024140
Exon 2	Y20C	p.Tyr49Cys	c.146A>G	substitution	1	A>G	Likely pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	India/		2012-10-23	Sanjeeva GN Barat M Dumont B Touitou I   Personal communication
Exon 2	H22Y	p.His51Tyr	c.151C>T	substitution	1	C>T	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	scottish/german/Caucasian		2002-01-25	Aksentijevich I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543
Exon 2	H22R	p.His51Arg	c.152A>G	substitution	1	A>G	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN			200	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/Caucasian		2008-12-08	Rowczenio DM  Russell TL  Lachmann HJ  Hawkins PN    Personal communication
Exon 2	H22Q	p.His51Gln	c.153C>G	substitution	1	C>G	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN			130	Heteroduplex Sequencing Sanger 	UNKNOWN	Symptomatic 	Juvenile Idiopathic Arthritis 	/Caucasian	 	2004-02-10	Aganna  E  Hawkins PN  Ozen  S  Pettersson  T  Bybee  A  McKee  SA  Lachmann  HJ  Karenko L  Ranki A  Bakkaloglu A  Besbas N  Topaloglu R  Hoffman HM  Hitman GA  Woo P  and McDermott MF.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15071491
Exon 2	N25D	p.Asn54Asp	c.160A>G	substitution	1	A>G	Uncertain significance (VOUS)	PROVISIONAL	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Japan/Asian	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication	2011-09-02	Nakamura M   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/20400394
Exon 2	S27S	p.(=)	c.168G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO			300	DGGE Sequencing Sanger 	destroys TaqI t/cga	Unknown	Recurrent Fever 	Italy/		2006-06-15	Manna  R  Dumont  D  Fabre  A  Touitou  I   Personal communication
Exon 2	I28S	p.Ile57Ser	c.170T>G	substitution	1	T>G	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	UNKNOWN			500	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/Caucasian		2012-07-03	Rowczenio DM  Trojer H  Lachmann HJ  Hawkins PN    Personal communication
Exon 2	C29R	p.Cys58Arg	c.172T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Turkey/Caucasian		2011-05-17	Cosan F et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/20532935
Exon 2	C29G 	p.Cys58Gly	c.172T>G	substitution	1	T>G	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Unknown	TRAPS 	Argentina/		2013-08-16	DeCunto C  Gattorno M  Ceccherini I   Personal communication
Exon 2	C29F	p.Cys58Phe	c.173G>T	substitution	1	G>T	Pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Netherlands/	   	2002-02-12	Simon A   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11700162
Exon 2	C29Y	p.Cys58Tyr	c.173G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			400	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	India/	Disrupts intrachain disulfide bond	2006-03-09	D'Osualdo  A. and Ceccherini  I.   Personal communication
Exon 2	C29S	p.Cys58Ser	c.173G>C	substitution	1	G>C	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Unknown 	UNKNOWN	Unknown	TRAPS 	/		2013-02-05	Toplak N et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22377804
Exon 2	C29W	p.Cys58Trp	c.174C>G	substitution	1	C>G	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Poland/		2017-08-18	Isabella Ceccherini   Personal communication
Exon 2	C30R	p.Cys59Arg	c.175T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	NO	Symptomatic 	TRAPS 	Irish-American/Caucasian	Disrupts intrachain disulfide bond	2002-01-02	Mc Dermott MF et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10199409
Exon 2	C30S	p.Cys59Ser	c.176G>C	substitution	1	G>C	Pathogenic	VALIDATED	UNKNOWN	NO			120	Sequencing Sanger 	destroys RsaI gt/ac	Symptomatic 	TRAPS 	France/	Disrupts intrachain disulfide bond	2002-01-03	Dodé C   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10902757
Exon 2	C30Y	p.Cys59Tyr	c.176G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			200	Sequencing Sanger 	NO	Symptomatic 	TRAPS 	Italy/	de novo mutation  Disrupts intrachain disulfide bond	2004-10-05	Obici L  Marciano S  Palladini  G  Lavatelli  F  Donadei S  Cigni  A  Satta  A.E  Praderio  L  Tresoldi  M  Merlini G.   Congress abstract:Xth International Symposium on Amyloid and Amyloidosis, Tours, France, April 2004
Exon 2	C30F	p.Cys59Phe	c.176G>T	substitution	1	G>T	Pathogenic	VALIDATED	UNKNOWN	NO			300	DGGE RFLP Sequencing Sanger 	destroys RsaI gt/ac	Symptomatic 	TRAPS 	France/		2007-05-21	Marcq L  Fabre A  Dumont B  Touitou  I   Personal communication
Exon 2	C33G	p.Cys62Gly	c.184T>G	substitution	1	T>G	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Puerto rico/	Disrupts intrachain disulphide bond	2002-01-08	Aksentijevich I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543
Exon 2	C33Y	p.Cys62Tyr	c.185G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	creates ScaI agt/act	Symptomatic 	TRAPS 	Irish-Scottish/Caucasian	Disrupts intrachain disulfide bond	2002-01-02	Mc Dermott et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10199409
Intron 2	c.194-80C>T		c.194-80C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			98	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Italy/Caucasian		2011-12-22	Lucherini OM  Vitali  A  Baldari  CT  Galeazzi  M  Cantarini  L   Personal communication
Intron 2	c.194-29G>A		c.194-29G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO			150	DGGE Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	France/Maghrebian	 	2005-01-06	Kessentini M  Chaabouni H  Dumont B  Touitou I   Personal communication
Intron 2	c.194-18_-17delCT		c.194-18_194-17del	deletion	2	CT	Not classified		UNKNOWN	NO			1100	Sequencing Sanger 	creates BsiYI ccnnnnn/nngg	Unknown	NO	Germany/	 	2006-01-09	Lohse P   Personal communication
Intron 2	c.194-15C>T		c.194-15C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			540	Sequencing Sanger 	destroys Fnu4HI gc/ngc	Unknown	UNKNOWN	Turkey/	  	2004-12-07	Lohse P  Fuchs  A   Personal communication
Intron 2	c.193-14G>A		c.194-14G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	YES	Unknown  	Creation of splice acceptor site  	100	Sequencing Sanger 	UNKNOWN	Symptomatic 	UNKNOWN	United kingdom/	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication (usual name)   It is identified in intron 2 (intron following exon2) at the position -14 relative to the Glycine codon 65. It results in a transcript encoding four additional extracellular amino acids.  	2003-02-12	I. Aksentijevich et al.  2001  AJHG   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543
Exon 3	G36E	p.Gly65Glu	c.194G>A	substitution	1	G>A	Likely pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	UNKNOWN	Spain/	De novo mutation  RT-PCR studies indicate no aberrant mRNA splicing	2002-11-18	Aldea A  Arostegui JI  Solis P   Yagüe J   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15549379
Exon 3	T37I	p.Thr66Ile	c.197C>T	substitution	1	C>T	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN			100	RFLP Sequencing Sanger 	destroys RsaI gt/ac	Symptomatic 	TRAPS 	Germany/	normal TNFRSF1A shedding 	2003-04-23	Aganna et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/13130484
Exon 3	Y38C	p.Tyr67Cys	c.200A>G	substitution	1	A>G	Likely pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Netherlands/	   	2002-02-12	Simon A   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11700162
Exon 3	Y38S	p.Tyr67Ser	c.200A>C	substitution	1	A>C	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN			200	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/Caucasian		2009-11-02	Rowczenio  DM  Trojer  H  Lachmann HJ  Hawkins PN   Personal communication
Exon 3	L39F	p.Leu68Phe	c.204G>C	substitution	1	G>C	Likely pathogenic	VALIDATED	UNKNOWN	NO			150	DGGE Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Spain/		2005-02-28	Monnier  A  Domingo-Rittore  C  Zarouri  S  Touitou  I.   Personal communication
Exon 3	D42DEL	p.Asp71del	c.211_213delGAC	deletion	3	GAC	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN		In frame deletion/insertion  	50	RFLP Sequencing Sanger dHPLC 	creates MfeI c/aattg	Symptomatic 	TRAPS 	United kingdom/	normal TNFRSF1A shedding	2003-05-16	Aganna E  Hammond L  Hawkins PN  Aldea A  McKee SA  Ploos van Amstel HK  et al.  McDermott MF   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/13130484
Exon 3	D42E	p.Asp71Glu	c.213C>A	substitution	1	C>A	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN		missense mutation  		Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Georgia/Caucasian		2014-09-22	Jéru I  Cochet E  Amselem S   Personal communication
Exon 3	C43R	p.Cys72Arg	c.214T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	NO			200	Sequencing Sanger 	NO	Symptomatic 	TRAPS 	Italy/	de novo mutation  Disrupts intrachain disulphide bond	2002-10-31	Obici L  Palladini G  Marciano S  Massa M  Zoppo M  Merlini G.   Congress abstract:"Third International conference on FMF and hereditary inflammatory disorders, La Grande Motte, France; September 23-27,2002"
Exon 3	C43G	p.Cys72Gly	c.214T>G	substitution	1	T>G	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN			500	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/Caucasian		2011-05-26	Rowczenio DM  Wang G  Bybee A  Lachmann HJ  Hawkins PN    Personal communication
Exon 3	C43Y	p.Cys72Tyr	c.215G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			200	Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	France/		2004-02-05	Tchernitchko D   Personal communication
Exon 3	C43S	p.Cys72Ser	c.215G>C	substitution	1	G>C	Pathogenic	VALIDATED	UNKNOWN	YES	Unknown  	Unknown  	734	Sequencing Sanger 	NO	Symptomatic 	TRAPS 	United kingdom/	Disrupts intrachain disulphide bond	2005-05-09	Siebert  S  Amos  N  Fielding   CA  Wang  ECY  Aksentijevich  I  Williams  BD  Brennan  P   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15818692
Exon 3	C43F	p.Cys72Phe	c.215G>T	substitution	1	G>T	Pathogenic	VALIDATED	UNKNOWN	NO		missense mutation  		Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	France / Spain/Caucasian		2014-09-22	Jéru I  Cochet C  Amselem S   Personal communication
Exon 3	P46L	p.Pro75Leu	c.224C>T	substitution	1	C>T	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	YES	Unknown  	Unknown  	326	Sequencing Sanger 	creates StuI agg/cct	Symptomatic 	TRAPS 	Unknown/	impaired TNFRSF1A shedding - Low penetrance mutation	2002-03-18	Aksentijevich I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543
Exon 3	G47G	p.(=)	c.228G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO			400	Sequencing Sanger 	UNKNOWN	Non symptomatic 	NO	Italy/		2006-03-09	D'Osualdo A  and Ceccherini  I.   Personal communication
Exon 3	T50M	p.Thr79Met	c.236C>T	substitution	1	C>T	Pathogenic	VALIDATED	UNKNOWN	YES	Unknown  	Unknown  	100	Sequencing Sanger 	destroys SnaBI tac/gta	Symptomatic 	TRAPS 	Unknown/	impaired TNFRSF1A shedding	2002-01-02	Mc Dermott MF et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10199409
Exon 3	T50K	p.Thr79Lys	c.236C>A	substitution	1	C>A	Likely pathogenic	VALIDATED	UNKNOWN	YES	Unknown  		50	RFLP Sequencing Sanger 	destroys RsaI gt/ac	Symptomatic 	TRAPS Proband has CNS disease with abnormal MRI	Germany/	impaired TNFRSF1A shedding	2003-09-16	Aganna E  et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/13130484
Exon 3	C52R	p.Cys81Arg	c.241T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN			200	Sequencing Sanger 	destroys PstI ctgca/g	Symptomatic 	UNKNOWN	Spain/	normal TNFRSF1A shedding	2002-06-18	Aldea A  Arostegui JI  Campistol JM  Yagüe J   Personal communication
Exon 3	C52F	p.Cys81Phe	c.242G>T	substitution	1	G>T	Pathogenic	VALIDATED	UNKNOWN	YES	Unknown  	Unknown  	100	Sequencing Sanger 	destroys PstI ctgca/g	Symptomatic 	TRAPS 	Unknown/	impaired TNFRSF1A shedding  Disrupts intrachain disulfide bond	2002-01-02	Mc Dermott MF et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10199409
Exon 3	C52Y	p.Cys81Tyr	c.242G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			400	Sequencing Sanger 	destroys PstI ctgca/g	Symptomatic 	TRAPS 	Italy/		2006-03-09	D'Osualdo et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16508982
Exon 3	C52S	p.Cys81Ser	c.242G>C	substitution	1	G>C	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Germany/Caucasian		2007-09-04	Kuemmerle-Deschner JB  Kallinich T  Haug M  Horstmann R  Dannecker  G  Benseler  S.   Congress abstract:C52S Mutation im Exon 3 des TNFRSF 1A Gens bei eineiigen Zwillingen mit TRAPS. J.B. Kuemmerle-Deschner, R. Horstmann, G.E. Dannecker.  AGKJR, Garmisch, Germany 2003
Exon 3	C52W	p.Cys81Trp	c.243C>G	substitution	1	C>G	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United states/Caucasian	early onset attacks lasting up to 21 days 	2010-01-29	Aksentijevich I   Personal communication
Exon 3	R53G	p.Arg82Gly	c.244A>G	substitution	1	A>G	Uncertain significance (VOUS)	PROVISIONAL	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Unknown	TRAPS 	Italy/Caucasian		2013-08-16	Gattorno M  Ceccherini I   Personal communication
Exon 3	E54E	p.(=)	c.249G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO		No effect  	200	Sequencing Sanger 	UNKNOWN	Non symptomatic 	NO	Spain/Maghrebian	 	2005-07-26	AROSTEGUI  JI  ANTON  J  YAGUE  J   Personal communication
Exon 3	C55R	p.Cys84Arg	c.250T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	NO			200	Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	France/		2004-02-05	Tchernitchko D   Personal communication
Exon 3	C55S	p.Cys84Ser	c.251G>C	substitution	1	G>C	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	creates HinfI g/antc	Symptomatic 	TRAPS 	Belgium/	Disrupts intrachain disulphide bond	2002-01-03	Jadoul M   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11318938
Exon 3	C55Y	p.Cys84Tyr	c.251G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			400	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Italy/	Disrupts intrachain disulfide bond	2006-03-09	D'Osualdo et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16508982
Exon 3	S57_E64del	p.Ser86_Glu93del	c.255_278del	deletion	24	GAGCGGCTCCTTCACCGCTTCAGA	Likely pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	TRAPS 	United kingdom/	Gonosomal mosaicism	2013-07-19	Rowczenio D et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/26992170
Exon 3	E56D	p.Glu85Asp	c.255G>C	substitution	1	G>C	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Germany/Turkish	Beside the index patient there were 4 more symptomatic family members with the same mutation	2015-07-31	Horneff G1  Rhouma A  Weber C  Lohse P   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/24064022
Exon 3	G58S	p.Gly87Ser	c.259G>A	substitution	1	G>A	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Unknown	TRAPS 	Brazil/		2013-02-05	Jesus AA et al   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/22566169
Exon 3	S59P	p.Ser88Pro	c.262T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	YES	Unknown  	Altered regulation  	100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Italy/Caucasian	The S59P mutation leads to defective cellular trafficking and to constitutive activation of TNF-R1. This mutation also determines constitutive activation of the IL-1R pathway, inhibition of apoptosis and enhanced and persistent NF-&#954;B activation and cytokine secretion in response to IL-1&#946; stimulation.	2009-10-17	Obici L  Donadei S  Punzi L  Merlini G   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/25888769
Exon 3	F60L(264C>G)	p.Phe89Leu	c.265T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	NO			50	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication	2003-05-07	Aganna E et al. 2003   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/13130484
Exon 3	F60V	p.Phe89Val	c.265T>G	substitution	1	T>G	Likely pathogenic	VALIDATED	UNKNOWN	NO			1130	Sequencing Sanger 	creates MaeIII /gtnac	Symptomatic 	UNKNOWN	Germany/	   	2006-01-23	Haas SL  Lohse P  Schmitt WH  Hildenbrand R  Karaorman M  Singer MV  Böcker U    Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16401480
Exon 3	F60S	p.Phe89Ser	c.266T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	NO			360	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	/		2006-05-12	Roesler J   Personal communication
Exon 3	F60L(267A>G)	p.Phe89Leu	c.267C>A	substitution	1	C>A	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS Vomiting, Cervical lymphadenopathy	Turkey/	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication (usual name)	2005-12-12	A. Dinc  H. Erdem  D. Rowczenio  I. Simsek  S. Pay  M. Bahce  H. Lachmann   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16299693
Exon 3	T61P	p.Thr90Pro	c.268A>C	substitution	1	A>C	Not classified		UNKNOWN	NO		No effect  		Sequencing Sanger Sequencing NGS 	UNKNOWN	Symptomatic 	TRAPS 	United states/Caucasian		2016-12-30	Radhakrishnan  SM  Grimm  AE  Broderick  L   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/?term=28427379
Exon 3	T61I	p.Thr90Ile	c.269C>T	substitution	1	C>T	Likely pathogenic	PROVISIONAL	UNKNOWN	NO				Sequencing Sanger 	destroys HphI ggtga	Symptomatic 	Systemic Lupus Erythematosus 	Japan/	   	2004-08-05	Ida H  Kawasaki E  Miyashita T  Tanaka F  Kamachi M  Izumi Y  Huang M  Tamai M  Origuchi T  Kawakami A  Migita K  Motomura M  Yoshimura T  Eguchi K   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15280569
Exon 3	T61N	p.Thr90Asn	c.269C>A	substitution	1	C>A	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Netherlands/Caucasian		2008-08-05	van Gijn  ME   Personal communication
Exon 3	N65I	p.Asn94Ile	c.281A>T	substitution	1	A>T	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	NO	Symptomatic 	TRAPS 	Estonia/	normal TNFRSF1A shedding 	2003-04-23	Frenkel J Ploos van Amstel  JK  Lasham  C  Gaiser  N  Rijkers  GT   Congress abstract:FMF2002, La Grande Motte, France, sept 23-27 2002
Exon 3	N65K	p.Asn94Lys	c.282C>G	substitution	1	C>G	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN			500	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/Caucasian		2015-07-20	 Trojer H  Rowczenio DM    Lachmann HJ  Hawkins PN     Personal communication
Exon 3	H66Y	p.His95Tyr	c.283C>T	substitution	1	C>T	Likely pathogenic	PROVISIONAL	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United states/Caucasian		2008-12-22	Aksentijevich I   Personal communication
Exon 3	H66L	p.His95Leu	c.284A>T	substitution	1	A>T	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN			200	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/Asian / British		2010-02-09	Rowczenio DM  Trojer  H  Lachmann HJ  Hawkins PN    Personal communication
Exon 3	H66P	p.His95Pro	c.284A>C	substitution	1	A>C	Likely pathogenic	PROVISIONAL	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Australia/Caucasian	Father with same clinical phenotype - genetic testing not performed.	2013-08-30	Akikusa JD   Personal communication
Exon 3	L67P	p.Leu96Pro	c.287T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	France/	  	2002-06-25	Dodé C   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/12209523
Exon 3	H69fs	p.His98_Cys99delinsArg	c.293_295del	deletion	3	ACT	Likely pathogenic	VALIDATED	UNKNOWN	NO			100	DGGE Heteroduplex Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	France/	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication (usual name)	2005-01-11	Federici  L et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16707534
Exon 3	C70R	p.Cys99Arg	c.295T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN			200	Sequencing Sanger 	destroys AlwNI cagnnn/ctg	Symptomatic 	TRAPS 	Israel/Arab	Disrupts intrachain disulphide bond	2002-02-12	Aganna E   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11817598
Exon 3	C70S	p.Cys99Ser	c.295T>A	substitution	1	T>A	Pathogenic	VALIDATED	UNKNOWN	NO			20	Sequencing Sanger 	NO	Symptomatic 	TRAPS       	Japan/	Disrupts intrachain disulphide bond	2002-12-11	Kusuhara K  Nomura A  Nakao F  Hara T   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/14610673
Exon 3	C70G	p.Cys99Gly	c.295T>G	substitution	1	T>G	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN			200	Sequencing Sanger SSCP 	UNKNOWN	Symptomatic 	TRAPS 	Japan/	Disrupts intrachain disulphide bond	2004-10-25	Horiuchi T et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15492850
Exon 3	C70Y	p.Cys99Tyr	c.296G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	NO	Symptomatic 	TRAPS 	Dutch/Indonesian/Dutch/Indonesian	Disrupts intrachain disulphide bond	2002-03-18	Simon A   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11239851
Exon 3	C73R	p.Cys102Arg	c.304T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	NO			50	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Finland/	Disrupts intrachain disulphide bond	2002-09-21	Stjernberg S  Pettersson T  Karenko L  Pitkänen S  Blazevic V  Peterson P  Ranki A.   Congress abstract:Third International Conference on Familial Mediterranean Fever and Hereditary Inflammatory Disorders, Montpellier, France, 23.-27.09.2002.
Exon 3	C73W	p.Cys102Trp	c.306C>G	substitution	1	C>G	Likely pathogenic	VALIDATED	UNKNOWN	NO				RFLP Sequencing Sanger 	creates AvaII g/gwcc	Symptomatic 	UNKNOWN	/Caucasian		2003-10-20	Touitou I  Domingo Rittore C  Vougiouka O   Personal communication
Exon 3	S74C	p.Ser103Cys	c.308C>G	substitution	1	C>G	Likely pathogenic	VALIDATED	UNKNOWN	NO			192	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	European/		2007-05-21	Aksentijevich  I   Personal communication
Exon 3	C105Y	p.Cys105Tyr 	c.314G>A	substitution	1	G>A	Likely pathogenic	VALIDATED	UNKNOWN	NO			>900	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Netherlands/Caucasian		2017-08-18	M.E. vanGijn   Personal communication
Intron 3	323-32A>G		c.323-32A>G	substitution	1	A>G	Likely benign	VALIDATED	UNKNOWN	NO			1950	Sequencing Sanger 	creates FauI cccgc	Symptomatic 	NO	Germany/	The affected individual was also a heterozygous carrier of the p.Arg121Gln/R92Q mutation.	2007-01-06	Lohse P  Kümpfel T  Rübsamen H   Personal communication
Exon 4	Q82K	p.Gln111Lys	c.331C>A	substitution	1	C>A	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	UNKNOWN			1376	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United states/Caucasian		2010-07-27	Overman  L   Personal communication
Exon 4	V83L	p.Val112Leu	c.334G>T	substitution	1	G>T	Likely pathogenic	PROVISIONAL	UNKNOWN	NO			1376	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United states/Caucasian		2009-12-19	Overman  L   Personal communication
Exon 4	V83M 	p.Val112Met	c.334G>A	substitution	1	G>A	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN			500	Sequencing Sanger 	UNKNOWN	Symptomatic 	UNKNOWN	United kingdom/Caucasian		2012-07-03	Rowczenio DM  Trojer H  Lachmann HJ  Hawkins PN    Personal communication
Exon 4	S86P	p.Ser115Pro	c.343T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	scottish/irish/Caucasian		2002-01-14	Aksentijevich I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543
Exon 4	C88R	p.Cys117Arg	c.349T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	creates TaqI t/cga	Symptomatic 	TRAPS 	United kingdom/	Disrupts intrachain disulfide bond	2002-01-02	Mc Dermott MF et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10199409
Exon 4	C88Y	p.Cys117Tyr	c.350G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	destroys HinP1I g/cgc	Symptomatic 	TRAPS 	Finland/	Disrupts intrachain disulphide bond	2002-01-02	Mc Dermott MF et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10199409
Exon 4	C88S	p.Cys117Ser	c.350_351delinsCA	delins	2 deleted/2 inserted	GC / CA	Likely pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Germany/Caucasian		2011-08-02	J. Trübenbach · G. Wildhardt · J. Niebel · H. Hawle · Daniela Steinberger   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19547977
Exon 4	T89A	p.Thr118Ala	c.352A>G	substitution	1	A>G	Uncertain significance (VOUS)	PROVISIONAL	UNKNOWN	NO			345	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS TRAPS/HIDS overlapping phenotype	United states/Caucasian		2010-04-06	Saulsbury FT et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/20346247
Exon 4	R92W	p.Arg121Trp	c.361C>T	substitution	1	C>T	Likely pathogenic	PROVISIONAL	UNKNOWN	NO			1270	Sequencing Sanger 	creates BsrI actgg	Symptomatic 	TRAPS 	Germany/		2006-04-05	Jeru I et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/23894535
Exon 4	R92P	p.Arg121Pro	c.362G>C	substitution	1	G>C	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN			120	Sequencing Sanger 	creates SplI c/gtacg	Symptomatic 	TRAPS 	Netherlands/	 	2002-01-03	Aganna E   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11175303
Exon 4	R92Q	p.Arg121Gln	c.362G>A	substitution	1	G>A	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	UNKNOWN			200	Sequencing Sanger 	destroys NciI cc/sgg	Symptomatic 	Early Arthritis TRAPS 	European populations/Caucasian	normal TNFRSF1A shedding - Low penetrance mutation	2002-01-25	Aksentijevich I   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543
Exon 4	D93H	p.Asp122His	c.364G>C	substitution	1	G>C	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Unknown	TRAPS 	Brazil/		2013-02-05	Jesus AA et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22566169
Exon 4	D93E	p.Asp122Glu	c.366C>G	substitution	1	C>G	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	NO			500	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Netherlands/Netherlands		2013-05-06	Marielle Van Gijn   Personal communication
Exon 4	T94T	p.(=)	c.369C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			540	Sequencing Sanger 	UNKNOWN	Non symptomatic 	TRAPS 	Germany/	 	2004-12-10	Lohse P  Fuchs A   Personal communication
Exon 4	V95M	p.Val124Met	c.370G>A	substitution	1	G>A	Likely pathogenic	VALIDATED	UNKNOWN	NO			1300	Sequencing Sanger 	creates NlaIII catg/	Symptomatic 	TRAPS 	Germany/		2006-04-13	Rack A  Stojanov S  Belohradsky BH  Lohse P   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/16635178
Exon 4	C96R	p.Cys125Arg	c.373T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN			1000	Sequencing Sanger Sequencing NGS 	UNKNOWN	Symptomatic 	Juvenile Idiopathic Arthritis TRAPS 	/		2017-08-16	Pajot C  Sarrabay G  Rittore C  Touitou I   Personal communication
Exon 4	C96Y	p.Cys125Tyr	c.374G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Slovakia/	Disrupts intrachain disulphide bond	2002-06-25	Dodé C   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/12209523
Exon 4	C96F	p.Cys125Phe	c.374G>T	substitution	1	G>T	Pathogenic	VALIDATED	UNKNOWN	NO			300	Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	France/Maghrebian		2012-10-30	Blanc F Dumont B Philibert L Touitou I   Personal communication
Exon 4	C96W	p.Cys125Trp	c.375T>G	substitution	1	T>G	Pathogenic	VALIDATED	UNKNOWN	NO			1000	Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	Oman/Arab		2014-09-26	Abrawi S  Dumont D  Tachon T  Sarrabay G  Touitou I   Personal communication
Exon 4	C98R	p.Cys127Arg	c.379T>C	substitution	1	T>C	Pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Unknown 	UNKNOWN	Unknown	TRAPS 	/		2013-02-05	Toplak N et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22377804
Exon 4	C98Y	p.Cys127Tyr	c.380G>A	substitution	1	G>A	Pathogenic	VALIDATED	UNKNOWN	NO			50	RFLP Sequencing Sanger 	destroys PstI ctgca/g	Symptomatic 	UNKNOWN	Denmark/	 	2003-02-14	Weyhreter H et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/12584543
Exon 4	N101K	p.Asn130Lys	c.390C>G	substitution	1	C>G	Likely pathogenic	PROVISIONAL	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Japan/Asian	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication	2011-09-02	Nakamura M   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/19673872
Exon 4	Y103_R104DEL	p.Tyr132_Arg133del	c.394_399del	deletion	6	TACCGG	Likely pathogenic	VALIDATED	UNKNOWN	NO			115	Sequencing Sanger 	destroys RsaI gt/ac	Symptomatic 	TRAPS recurrent pericarditis	Italy/Caucasian		2010-03-18	Lucherini OM  Cantarini  L  Baldari  CT  Laghi Pasini  F  Galeazzi  M   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/20074469
Exon 4	R104W	p.Arg133Trp	c.397C>T	substitution	1	C>T	Likely pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	creates ScaI agt/act	Symptomatic 	TRAPS 	Italy/	Recessive pattern	2015-03-11	Wong KKY et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/25744939
Exon 4	R104Q	p.Arg133Gln	c.398G>A	substitution	1	G>A	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	YES	Unknown  	Unknown  	200	Sequencing Sanger SSCP 	UNKNOWN	Unknown	Systemic Lupus Erythematosus 	Japan/	R104Q was found in 2 out of 100 Japanese unrelated SLE patients, which was not identified in 100 Japanese RA patients or 100 control subjects. 	2004-10-25	Horiuchi T et al.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/15492850
Exon 4	H105P	p.His134Pro	c.401A>C	substitution	1	A>C	Uncertain significance (VOUS)	PROVISIONAL	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Germany/		2007-07-09	Wendling D et al   Congress abstract:FMF2005, Bethesda, USA, November 2005
Exon 4	Y106C	p.Tyr135Cys	c.404A>G	substitution	1	A>G	Likely pathogenic	PROVISIONAL	UNKNOWN	NO			150	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	/		2013-08-27	Launay D  Dumont B  Barat-Houary M  Touitou I   Personal communication
Exon 4	E109A	p.Glu138Ala	c.413A>C	substitution	1	A>C	Likely benign	PROVISIONAL	UNKNOWN	UNKNOWN			200	Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	United kingdom/		2008-02-25	Rowczenio DM  Russell TL  Lachmann HJ  Hawkins PN    Personal communication
Exon 4	F112I	p.Phe141Ile	c.421T>A	substitution	1	T>A	Pathogenic	VALIDATED	UNKNOWN	YES	Unknown  		50	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Finland/	impaired TNFRSF1A shedding	2002-06-25	Nevala H et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11953985
Exon 4	F112L	p.Phe141Leu	c.421T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Unknown	TRAPS 	Brazil/		2013-02-05	Jesus AA et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/22566169
Exon 4	F112C	p.Phe141Cys	c.422T>G	substitution	1	T>G	Likely pathogenic	VALIDATED	UNKNOWN	NO			200	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Italy/Caucasian		2010-08-31	Obici L  Trevisson E  Zulian F   Personal communication
Exon 4	F112S	p.Phe141Ser	c.422T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United states/Caucasian		2012-06-15	Aksentijevich I.   Personal communication
Exon 4	C143R	p.Cys143Arg  	c.427T>C	substitution	1	T>C	Likely pathogenic	VALIDATED	UNKNOWN	NO			>999	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Belgium/Caucasian		2017-08-18	M.E. van Gijn   Personal communication
Exon 4	C114W	p.Cys143Trp	c.429C>G	substitution	1	C>G	Likely pathogenic	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Italy/Caucasian		2013-07-03	Obici L  Donadei S  Merlini G   Personal communication
Exon 4	N116S	p.Asn145Ser	c.434A>G	substitution	1	A>G	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Symptomatic 	UNKNOWN	Turkey/		2008-08-05	van Gijn  ME   Personal communication
Exon 4	T124T	p.(=)	c.459C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	NO	Unknown	Recurrent Arthritis A 46 years old Turkish female who has been suffering from adult onset Still&#8217;s disease since the age of 39 was in remission with methyl prednisolone and Methotrexate treatment for 5 years. At age 39, she had experienced severe hemophagocytic syndrome at the first onset of her symptoms and she was treated with high dose steroid regimen for a couple of weeks until remission of hemophagocytic syndrome. Then methotrexate was added to her regimen and her steroid dose has been tapered gradually. She has recently been on methyl prednisolone (8 mg/day) and Methotrexate (10 mg/week). She recently is admitted to the hospital with urticarial lesions lasting for 2 months, without fever and arthralgias. Her CRP and ESR levels are slightly elevated and her ferritin level is normal. After rising of methyl prednisolon, her urticarial lesions faded away and her CRP and ESR are normalized.	Turkey/Caucasian		2013-01-24	Erken E  Dinkci S  Arslan Tas D  Eroglu A   Personal communication
Exon 4	H126T	p.His155Tyr	c.463C>T	substitution	1	C>T	Not classified		UNKNOWN	NO				Sequencing Sanger Sequencing NGS 	UNKNOWN	Symptomatic 	Behçet's disease 	Spain/Caucasian		2016-10-13	Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano and María Francisca González-Escribano et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775
Intron 4	c.472+1G>A	p.Cys158delinsYERSSPEAKPSPHPRG	c.472+1G>A	substitution	1	G>A	Likely pathogenic	VALIDATED	UNKNOWN	YES	Unknown  	Aberrant mRNA splicing  	100	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	United kingdom/		2008-04-11	Churchman S et al   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/18086728
Intron 4	c.472+6C>T		c.472+6C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			1300	Sequencing Sanger 	destroys HinP1I g/cgc	Symptomatic 	NO	Turkey/	Position 6 of the donor splice site can be either T (55%), A (21%), G (14%), or C (10%; Zhang, MQ. 1998. Hum Mol. Genet. 7: 919-932). Therefore, splicing should not be affected.    	2006-04-13	Lohse P  Fuchs A  Schwarz A   Personal communication
Intron 4	c.472+17T>C		c.472+17T>C	substitution	1	T>C	Likely benign	VALIDATED	UNKNOWN	NO			500	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Netherlands/Netherlands		2013-05-06	Marielle Van Gijn   Personal communication
Intron 4	c.472+64C>T		c.472+64C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			1270	Sequencing Sanger 	destroys AciI ccgc	Symptomatic 	NO	Germany/	  	2006-04-05	Lohse P  Fuchs A  Becker S   Personal communication
Intron 4	c.473-72G>A		c.473-72G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	France/	 	2004-03-11	Touitou I  Domingo-Rittore C   Personal communication
Intron 4	c.473-33C>T		c.473-33T>C	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	Italy/	  	2003-04-25	Bazzoni F  et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/10663579
Intron 4	c.473-16 G>A		c.473-16G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO				DGGE Sequencing Sanger 	destroys AciI ccgc	Symptomatic 	UNKNOWN	France/	  	2004-01-09	Touitou I  Domingo Rittore C   Personal communication
Intron 5	c.552-89A>T		c.552-89A>T	substitution	1	A>T	Likely benign	VALIDATED	UNKNOWN	NO			750	Sequencing Sanger 	UNKNOWN	Non symptomatic 	NO	Turkey/	  	2005-05-19	Lohse P   Personal communication
Exon 6	K157K	p.(=)	c.558G>A	substitution	1	G>A	Likely benign	VALIDATED	UNKNOWN	NO			400	Sequencing Sanger 	UNKNOWN	Non symptomatic 	UNKNOWN	Italy/		2006-03-09	D'Osualdo A  and Ceccherini  I.   Personal communication
Exon 6	L167_G175del	p.Leu196_Gly204del	c.586_612del27	deletion	27	CTACCCCAGATTGAGAATGTTAAGGGC	Likely pathogenic	VALIDATED	UNKNOWN	NO			400	Sequencing Sanger 	UNKNOWN	Symptomatic 	UNKNOWN	Mauritius/		2006-03-09	D'Osualdo et al.   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/16508982
Exon 6	I170N	p.Ile199Asn	c.596T>A	substitution	1	T>A	Likely pathogenic	VALIDATED	UNKNOWN	NO			192	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS  	Germany/	 	2003-08-18	Kriegel MA  et al. Arthritis Rheum. 2003 Aug 48(8):2386-8   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/12905494
Exon 6	I170T	p.Ile199Thr	c.596T>C	substitution	1	T>C	Not classified		UNKNOWN	UNKNOWN				Sequencing Sanger Sequencing NGS 	UNKNOWN	Symptomatic 	Behçet's disease 	Spain/Caucasian		2017-07-13	Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano  María Francisca González-Escribano   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775
Exon 6	V173D	p.Val202Asp	c.605T>A	substitution	1	T>A	Likely pathogenic	PROVISIONAL	UNKNOWN	YES	Unknown  	Unknown  	2000	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS Cardiovascular complications	Austria/Caucasian		2008-01-11	Stojanov S  Dejaco C  Lohse P  Huss K  Duftner C  Belohradsky B  Herold M  Schirmer M    Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/18180277
Intron 6	c.625+10A/G		c.625+10A>G	substitution	1	A>G	Likely benign	VALIDATED	UNKNOWN	NO			71	RFLP Sequencing Sanger 	destroys BstEII g/gtnacc	Non symptomatic 	NO	Italy/	    	2003-07-14	Bazzoni F  Gatto L  Lenzi L  Vinante F  Pizzolo G  Zanolin E  De Gironcoli M.   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/10663579
Intron 6	c.625+53C>T		c.625+53C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	Italy/Caucasian		2014-10-03	Punzi L  Galozzi P  Sfriso P  Greco E  Moz S  Basso D  Plebani M   Personal communication
Intron 6	c.626-33 		c.626-33C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS A 18 year old Turkish male patient suffering from periodic fever beginning at the age of 2. Duration of the fever has been 3-10days, which repeated in every 2-3 months. He has aphthous stomatitis during most attacks lasting 1 or 2 weeks. Cervical lymphadenopathy accompanied to some attacks. At age of 17, he experienced monoarthritis on the left hand, third PIP which lasted 1 week. He had also myalgia during febrile attacks. Colchicine was started at the age of 13, according to the result of heterozygous E148Q MEFV mutation. He did not have any other exon 2 and exon 10 mutations which were searched by sequencing.His attacks did not respond colchicine prophylaxis. During attacks, his CRP and SAA levels were elevated(e.g; CRP:20-99 mg/dl, SAA:146-980 mg/l).He responded fairly to nonsteroidal antiinflammatory drugs.	Turkey/Caucasian	 	2012-02-21	Erken E  Dinkçi S  Yildirim M  Eroglu A   Personal communication
Intron 6	c.626-32G>T		c.626-32G>T	substitution	1	G>T	Likely benign	VALIDATED	UNKNOWN	NO			95	Sequencing Sanger 	UNKNOWN	Symptomatic 	Periodic Fever	Italy/Caucasian		2010-09-29	Lucherini OM  Cantarini L  Baldari CT  Laghi Pasini F  Brizi MG  Galeazzi M   Personal communication
Exon 7	S197C	p.Ser226Cys	c.677C>G	substitution	1	C>G	Uncertain significance (VOUS)	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Turkey/Caucasian	A 61 year old Turkish female. She has had rare polyarticular arthritic attacks since age 12.  She has been experiencing attacks of fever, periorbital edema and maculopapular skin rashes on her face,neck and arms lasting more than 2 weeks, since age of 53. Some of her attacks accompany with polarticular arthritis. Her attacks partially responded to methyl prednisolone treatment.She has been diagnosed as Primary Sjögren's Syndrome as well, since age of 57, which was proven by minor lacrimal gland biopsy.	2011-10-13	Erken E  Dinkci S  Eroglu A  Yildiz F   Personal communication
Exon 7	S197S	p.(=)	c.678C>G	substitution	1	C>G	Likely benign	VALIDATED	UNKNOWN	NO			550	Sequencing Sanger 	destroys MnlI cctc	Non symptomatic 	NO	Slovakia/	 	2004-11-26	Lohse P   Vesely R   Personal communication
Intron 7	c.218-9T>C		c.740-9T>C	substitution	1	T>C	Likely benign	VALIDATED	UNKNOWN	NO			100	Sequencing Sanger 	UNKNOWN	Unknown	UNKNOWN	Unknown/	The sequence and/or protein name of this variant has been edited as compared to that in the initial publication (usual name)	2003-08-05	Aksentijevich I. et al.  2001  AJHG   Publication (Medline Abstract): http://www.ncbi.nlm.nih.gov/pubmed/11443543
Intron 8	c.768+42delA		c.768+42delA	deletion	1	A	Likely benign	VALIDATED	UNKNOWN	NO			50	Sequencing Sanger 	UNKNOWN	Symptomatic 	Indeterminate colitis 	/		2013-06-06	Mathieu N  Philibert L  Dumont B  Prevot L  Touitou I   Personal communication
Intron 8	c.769-23T>C		c.769-23T>C	substitution	1	T>C	Likely benign	VALIDATED	UNKNOWN	NO				Sequencing Sanger 	UNKNOWN	Symptomatic 	UNKNOWN	/	Published on NCBI (CELERA/HuRef – AC_000055.1/NW_925295.1/AC_000144.1/NW_001838050.1)	2010-07-28	Dickie  LJ   Personal communication
Intron 8	c.769-5T>C		c.769-5T>C	substitution	1	T>C	Likely benign	VALIDATED	UNKNOWN	UNKNOWN				Sequencing Sanger 	UNKNOWN	Symptomatic 	Recurrent Fever 	/Caucasian		2017-09-05	Van Gijn M   Personal communication
Exon 9	R283K	p.Arg312Lys	c.935G>A	substitution	1	G>A	Not classified		UNKNOWN	UNKNOWN				Sequencing Sanger Sequencing NGS 	UNKNOWN	Symptomatic 	Behçet's disease 	Spain/Caucasian		2017-02-22	Sergio Burillo-Sanz  Marco-Antonio Montes-Cano  José-Raúl García-Lozano  María Francisca González-Escribano   Publication (Medline Abstract): https://www.ncbi.nlm.nih.gov/pubmed/28814775
Exon 10	L330L	p.(=)	c.1075C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			15	Sequencing Sanger 	UNKNOWN	Non symptomatic 	NO	France/Caucasian		2011-06-10	Rittore C  Grandemange S  Touitou I   Personal communication
Exon 10	Y331X	p.Tyr360*	c.1080C>G	substitution	1	C>G	Likely pathogenic	PROVISIONAL	UNKNOWN	NO			50	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Turkey/Caucasian		2009-03-30	Berdeli A Tigili D Aksu G Gulez N Karaca N  Kutukculer N.   Congress abstract:"ESID meet&#305;ng, 16-18 October 2008, The netherlands"
Exon 10	R341R	p.(=)	c.1110C>T	substitution	1	C>T	Likely benign	VALIDATED	UNKNOWN	NO			500	Sequencing Sanger 	UNKNOWN	Symptomatic 	TRAPS 	Netherlands/Netherlands		2013-05-06	Marielle Van Gijn   Personal communication
